68313-81-5

Usage

Uses

Used in Chemical Research:
(2R,6R,7R)-3-Methylene-7-(p-toluoylamino)-8-oxo-5-oxa-1-azabicyclo[4.2.0]octane-2-carboxylic acid diphenylmethyl ester is used as a research compound for exploring its chemical properties and reactivity. Its unique structure allows scientists to investigate its potential interactions with other molecules and its behavior under various conditions.
Used in Pharmaceutical Development:
In the pharmaceutical industry, (2R,6R,7R)-3-Methylene-7-(p-toluoylamino)-8-oxo-5-oxa-1-azabicyclo[4.2.0]octane-2-carboxylic acid diphenylmethyl ester is used as a precursor or intermediate in the synthesis of potential drug candidates. Its specific functional groups may offer opportunities for the development of new therapeutic agents with novel mechanisms of action.
Used in Drug Synthesis:
(2R,6R,7R)-3-Methylene-7-(p-toluoylamino)-8-oxo-5-oxa-1-azabicyclo[4.2.0]octane-2-carboxylic acid diphenylmethyl ester is utilized as a key component in the synthesis of complex drug molecules. Its presence in the molecular structure can influence the pharmacokinetics and pharmacodynamics of the final drug product, potentially leading to improved efficacy or reduced side effects.
Used in Material Science:
In material science, (2R,6R,7R)-3-Methylene-7-(p-toluoylamino)-8-oxo-5-oxa-1-azabicyclo[4.2.0]octane-2-carboxylic acid diphenylmethyl ester may be employed in the development of new materials with specific properties. Its incorporation into polymers or other materials could result in unique characteristics, such as enhanced stability or novel optical properties.

Upstream product

• 67977-95-1 diphenylmethyl 6β-(4-toluamido)penicillate 1-oxide 
• 104101-66-8 diphenylmethyl 6β-(4-toluamido)penicillanate 
• 91-01-0 1,1-Diphenylmethanol 
• 67978-05-6 C₂₉H₂₆N₂O₄ 
• 82468-41-5 C₂₉H₂₈N₂O₅S 
• 17028-66-9 6β-(4-toluamido)penicillanic acid 

Downstream Products

• 134237-56-2 (6R,7R)-benzhydryl (7-(2-difluoromethylthio)acetamido)-3-(chloromethyl)-7-methoxy-8-oxo-5-oxa-1-aza-bicyclo[4,2,0]oct-2-ene-2-carboxylate 
• 1370637-72-1 C₃₀H₂₆Cl₂N₂O₆S 
• 1370637-75-4 C₃₀H₂₅Cl₃N₂O₆S 
• 1370637-57-2 C₃₀H₂₈F₂N₃O₆S⁽¹⁺⁾*I^(1-) 
• 1370637-79-8 C₃₃H₃₂F₂N₃O₆S⁽¹⁺⁾*I^(1-) 
• 1370637-82-3 C₃₁H₂₈F₂N₅O₆S⁽¹⁺⁾*I^(1-) 
• 1370637-86-7 C₃₅H₃₁ClN₃O₆S⁽¹⁺⁾*I^(1-) 
• 1370637-89-0 C₃₈H₃₅ClN₃O₆S⁽¹⁺⁾*I^(1-) 
• 1370637-91-4 C₃₆H₃₁ClN₅O₆S⁽¹⁺⁾*I^(1-) 
• 1370637-94-7 C₃₅H₃₀Cl₂N₃O₆S⁽¹⁺⁾*I^(1-) 
• 1370637-97-0 C₃₈H₃₄Cl₂N₃O₆S⁽¹⁺⁾*I^(1-) 
• 1370638-00-8 C₃₆H₃₀Cl₂N₅O₆S⁽¹⁺⁾*I^(1-) 
• 91177-27-4 7-(N-4-methylbenzamide)-3-(chloromethyl)-8-oxo-5-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenylmethyl ester 
• 68314-38-5 (6R,7R)-benzhydryl 7-(4-methylbenzamide)-3-(chloromethyl)-7-methoxy-8-oxo-5-oxa-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate 

Relevant academic research and scientific papers

Preparation method of oxacephem parent nucleus intermediate

The invention discloses a preparation method of an oxacephem parent nucleus intermediate. The preparation method includes the following preparation steps that (1) dichloromethane is added to a reaction vessel, a compound OXAOH (001) is concentrated, dried

Design, synthesis and antibacterial activity of novel 1-oxacephem analogs

A series of 1-oxacephem analogs were synthesized and their antibacterial properties against five strains of Gram-positive and Gram-negative bacteria were evaluated in vitro while ceftazidine was selected as control. Some of the tested compounds, compound 12c in particular, showed more active against three selected strains than the standard.